{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:19:38Z","timestamp":1793344778049,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rabies is a uniformly fatal but vaccine-preventable disease. In India, the standard 4-session intradermal rabies post-exposure prophylaxis is currently administered. The World Health Organization has recommended a shortened 3-session regimen. Pediatric and adolescent-specific data for this abbreviated protocol remain sparse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To evaluate the immunogenicity of the 3-session intradermal rabies post-exposure prophylaxis regimen among children and adolescents under 18 years of age in India and to assess its adequacy for potential policy adoption.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A descriptive cross-sectional study was conducted at the Animal Bite Clinic of a tertiary teaching hospital in New Delhi, India. Eighty-two children and adolescents presenting for the 4th rabies vaccine dose were enrolled. Blood samples were collected before administration of the fourth dose, and IgG anti-rabies virus glycoprotein antibody values were estimated using indirect enzyme-linked immunosorbent assay. Values \u22650.5 EU\/mL were considered seroprotective. Participants were followed up for 1 year for any development of rabies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of the 82 participants, 79 (96.3%) had seroprotective values. The geometric mean value was 2.67 EU\/mL. Three participants (3.7%) had values &lt;0.5 EU\/mL. Follow-up assessment post-4th dose confirmed seroconversion in 2 of them. The use and type of rabies immunoglobulin had no significant effect on seroconversion. No participants developed rabies over a 1-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although seroconversion was achieved in 96.3% of participants after 3 sessions, the 3.7% with nonprotective values raise concerns. Given the fatal nature of rabies and infrastructural variability in Indian healthcare, continuation of the 4-session regimen is recommended until broader validation is conducted in a representative pediatric population via multicentric studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005004","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:02:48Z","timestamp":1758232968000},"page":"280-283","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity of Three-session Intradermal Rabies Post-exposure Prophylaxis in Indian Children and Adolescents"],"prefix":"10.1097","volume":"45","author":[{"given":"Anurag","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Maulana Azad Medical College & Associated Hospitals, New Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Rana","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Maulana Azad Medical College & Associated Hospitals, New Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-5036","authenticated-orcid":false,"given":"Surendra Bahadur","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Postgraduate Institute of Child Health, Noida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Manchanda","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Maulana Azad Medical College & Associated Hospitals, New Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashvi","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Dr Baba Saheb Ambedkar Medical College & Hospital, Delhi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeta","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pathology, Maulana Azad Medical College & Associated Hospitals, New Delhi, India."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"R1-20260615","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1473-3099(24)00490-0","article-title":"Estimates of the burden of human rabies deaths and animal bites in India, 2022-23: a community-based cross-sectional survey and probability decision-tree modelling study.","volume":"25","author":"Thangaraj","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"R3-20260615","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1016\/j.vaccine.2007.08.054","article-title":"Failures of post-exposure rabies prophylaxis.","volume":"25","author":"Wilde","year":"2007","journal-title":"Vaccine"},{"key":"R5-20260615","doi-asserted-by":"crossref","first-page":"fmab082","DOI":"10.1093\/tropej\/fmab082","article-title":"Estimating the Volume of Equine Rabies Immunoglobulin (eRIG) required for local infiltration in soft tissue animal bites in children using a wound size-based approach.","volume":"67","author":"Agarwal","year":"2021","journal-title":"J Trop Pediatr"},{"key":"R6-20260615","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S1473-3099(19)30311-1","article-title":"A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.","volume":"19","author":"Cantaert","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"R7-20260615","doi-asserted-by":"crossref","first-page":"A118","DOI":"10.1016\/j.vaccine.2018.10.054","article-title":"Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003\u20132014.","volume":"37","author":"Tarantola","year":"2019","journal-title":"Vaccine"},{"key":"R8-20260615","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1016\/j.vaccine.2010.06.102","article-title":"Seroconversion following incomplete human rabies postexposure prophylaxis.","volume":"28","author":"Robertson","year":"2010","journal-title":"Vaccine"},{"key":"R9-20260615","doi-asserted-by":"crossref","first-page":"100408","DOI":"10.1016\/j.onehlt.2022.100408","article-title":"Impact of the switch from four to three intradermal rabies post-exposure prophylaxis sessions in patients bitten by dogs: a cost-consequence analysis from the patients\u2019 perspective.","volume":"15","author":"Le Bras","year":"2022","journal-title":"One Health"},{"key":"R10-20260615","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/hv.2.5.3197","article-title":"Comparison of safety and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.","volume":"2","author":"Madhusudana","year":"2006","journal-title":"Hum Vaccin"},{"key":"R11-20260615","doi-asserted-by":"crossref","first-page":"585","DOI":"10.18203\/2394-6040.ijcmph20180233","article-title":"Clinical evaluation of purified chick embryo cell rabies vaccine administered intradermally in animal exposures.","volume":"5","author":"Hardanahalli","year":"2018","journal-title":"Int J Community Med Public Health"},{"key":"R13-20260615","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","article-title":"Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"R14-20260615","doi-asserted-by":"crossref","first-page":"taab060","DOI":"10.1093\/jtm\/taab060","article-title":"Diagnostic accuracy of ELISA kits for measurement of rabies antibodies.","volume":"28","author":"Ling","year":"2021","journal-title":"J Travel Med"},{"key":"R15-20260615","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4161\/hv.26456","article-title":"Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.","volume":"10","author":"Narayana","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R16-20260615","first-page":"491","article-title":"Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: a field trial in Indonesia. MAS054 Clinical Investigator Group.","volume":"76","author":"Lang","year":"1998","journal-title":"Bull World Health Organ"},{"key":"R17-20260615","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/s41598-022-10281-1","article-title":"Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters.","volume":"12","author":"Bernard","year":"2022","journal-title":"Sci Rep"},{"key":"R18-20260615","first-page":"967","article-title":"Post-exposure prophylactic vaccination against rabies: a systematic review.","volume":"51","author":"Ahmad","year":"2022","journal-title":"Iran J Public Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:00:23Z","timestamp":1781553623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005004","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]}}}